Table 1 Total number of COVID-19 cases averted owing to reduced risk in vaccinated individuals
Age group (years) | Vaccine dosea | Averted cases (95% confidence interval) | Relative change (%)b |
|---|---|---|---|
0–9 | Primary series | 603 (602–604) | -0.3 |
Booster | - | - | |
10–19 | Primary series | 65,755 (65,296–66,307) | -31.0 |
Booster | 2502 (2480–2532) | -1.7 | |
20–29 | Primary series | 61,872 (60 935–62,910) | -22.0 |
Booster | 16,909 (16 737–17,063) | -7.1 | |
30–39 | Primary series | 86,181 (84,743–87,503) | -29.7 |
Booster | 25,734 (25,382–26,015) | -11.2 | |
40–49 | Primary series | 45,851 (44,425–47,165) | -19.6 |
Booster | 23,027 (22,605–23,441) | -10.9 | |
50–59 | Primary series | 82,251 (80,529–83,825) | -43.4 |
Booster | 30,268 (29,656–30,858) | -22.0 | |
60–69 | Primary series | 30,667 (29,400–31,917) | -38.6 |
Booster | 14,240 (13,786–14,759) | -22.6 | |
70–79 | Primary series | 22,417 (21,182–23,432) | -40.8 |
Booster | 11,800 (11,169–12,389) | -26.6 | |
≥80 | Primary series | 82,424 (79,777–85,023) | -72.5 |
Booster | 37,101 (35,649–38,780) | -54.3 |